400 related articles for article (PubMed ID: 10757426)
21. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation.
Ko FN; Yeh LJ; Liang HC; Kuo SC; Teng CM
J Pharm Pharmacol; 1996 Apr; 48(4):395-400. PubMed ID: 8794990
[TBL] [Abstract][Full Text] [Related]
23. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans.
Ko FN; Chen IS; Wu SJ; Lee LG; Haung TF; Teng CM
Biochim Biophys Acta; 1990 May; 1052(3):360-5. PubMed ID: 2162213
[TBL] [Abstract][Full Text] [Related]
24. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
25. Antiplatelet effects of protopine isolated from Corydalis tubers.
Ko FN; Wu TS; Lu ST; Wu YC; Huang TF; Teng CM
Thromb Res; 1989 Oct; 56(2):289-98. PubMed ID: 2559491
[TBL] [Abstract][Full Text] [Related]
26. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
27. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina.
Tsai WJ; Hsieh HT; Chen CC; Kuo YC; Chen CF
Eur J Pharmacol; 1998 Apr; 346(1):103-10. PubMed ID: 9617759
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
32. Antiplatelet effects of clausine-D isolated from Clausena excavata.
Wu CC; Ko FN; Wu TS; Teng CM
Biochim Biophys Acta; 1994 Sep; 1201(1):1-6. PubMed ID: 7918571
[TBL] [Abstract][Full Text] [Related]
33. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Eur J Pharmacol; 1992 Jul; 218(1):129-35. PubMed ID: 1327822
[TBL] [Abstract][Full Text] [Related]
34. Anti-platelet activity of erythro-(7S,8R)-7-acetoxy-3,4,3',5'-tetramethoxy-8-O-4'-neolignan from Myristica fragrans.
Kang JW; Min BS; Lee JH
Phytother Res; 2013 Nov; 27(11):1694-9. PubMed ID: 23296979
[TBL] [Abstract][Full Text] [Related]
35. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
Chou TC; Hsu LY; Yen MH; Ding YA
Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
[TBL] [Abstract][Full Text] [Related]
36. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
37. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G
J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983
[TBL] [Abstract][Full Text] [Related]
38. The effect of 3-[2-(cyclopropylamino)ethoxy]xanthone on platelet thromboxane formation.
Chen WY; Ko FN; Lin CN; Teng CM
Thromb Res; 1994 Jul; 75(1):81-90. PubMed ID: 8073410
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of inhibition of platelet aggregation by HCL-31D.
Chou TC; Li CY; Lee AR; Wu TM
Eur J Pharmacol; 2000 Jan; 387(2):125-31. PubMed ID: 10650152
[TBL] [Abstract][Full Text] [Related]
40. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
